Evidence map›Paper›PMID 34697490›Full record

ArticleNature nanotechnology2021

Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects.

Changlong Wang, Wei Zhang, Yanjie He, Zirui Gao, Liyuan Liu, Siyao Yu, Yuxing Hu, Shuang Wang, Chaochao Zhao, Hui Li and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Changlong Wang *State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China.
Wei Zhang *Beijing National Laboratory for Molecular Engineering, College of Chemistry and Molecular Engineering and College of Engineering, and BIC-ESAT, Peking University, Beijing, P. R. China.
Yanjie He *Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China.
Zirui GaoBeijing National Laboratory for Molecular Engineering, College of Chemistry and Molecular Engineering and College of Engineering, and BIC-ESAT, Peking University, Beijing, P. R. China.
Liyuan LiuBeijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, P. R. China.
Siyao YuDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China.
Yuxing HuDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China.
Shuang WangState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China.ORCID http://orcid.org/0000-0002-9189-602X
Chaochao ZhaoBeijing National Laboratory for Molecular Engineering, College of Chemistry and Molecular Engineering and College of Engineering, and BIC-ESAT, Peking University, Beijing, P. R. China.
Hui LiBeijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, P. R. China.
Jinan ShiSchool of Physical Sciences and CAS Key Laboratory of Vacuum Sciences, University of Chinese Academy of Sciences, Beijing, P. R. China.
Wu ZhouSchool of Physical Sciences and CAS Key Laboratory of Vacuum Sciences, University of Chinese Academy of Sciences, Beijing, P. R. China.ORCID http://orcid.org/0000-0002-6803-1095
Feng LiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China.
Hua YueState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China.
Yuhua LiDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China. liyuhua1974@outlook.com.ORCID http://orcid.org/0000-0002-0982-6680
Wei WeiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China. weiwei@ipe.ac.cn.ORCID http://orcid.org/0000-0002-6244-3187
Guanghui MaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China. ghma@ipe.ac.cn.ORCID http://orcid.org/0000-0001-9154-5556
Ding MaBeijing National Laboratory for Molecular Engineering, College of Chemistry and Molecular Engineering and College of Engineering, and BIC-ESAT, Peking University, Beijing, P. R. China. dma@pku.edu.cn.ORCID http://orcid.org/0000-0002-3341-2998
Institute of Process Engineering · CNPeking University · CNZhujiang Hospital · CNBeijing University of Chemical Technology · CNUniversity of Chinese Academy of Sciences · CNGuangzhou Regenerative Medicine and Health Guangdong Laboratory · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trivalent arsenic (As

Indexed as

Drug Delivery SystemsAdolescentAdultAgedAnimalsAntigens, CDAntineoplastic AgentsArsenicCell DeathCell Line, TumorChildFemaleFerritinsHumansLeukemiaMaleAntigens, CDAntineoplastic AgentsArsenicCD71 antigenFerritinsReceptors, Transferrin

Identifiers

PMID34697490
OpenAlexW3211290742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.